Quick Answer
Vor Biopharma Inc. reported Shares Outstanding of 38.72 million shares for fiscal year 2025.
Vor Biopharma Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 38.72M | +520.6% |
| 2024 | 6.24M | -90.8% |
| 2023 | 67.89M | +2.9% |
| 2022 | 66.00M | +77.5% |
| 2021 | 37.17M | +7260.3% |
| 2020 | 505,074 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 9.03M | -86.9% | -92.8% |
| June 30, 2025 | 125.65M | +83.8% | +0.6% |
| March 31, 2025 | 124.85M | +83.0% | +1901.2% |
| December 31, 2024 | 6.24M | -90.8% | -90.9% |
| September 30, 2024 | 68.66M | +1.3% | +0.4% |
| June 30, 2024 | 68.36M | +1.4% | +0.2% |
| March 31, 2024 | 68.22M | +1.9% | +0.5% |
| December 31, 2023 | 67.89M | +2.9% | +0.2% |
- Vor Biopharma Inc. showed an increase of +520.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Vor Biopharma Inc.’s shares outstanding has grown by 7566.2% (from 505.1 thousand shares to 38.72 million shares).
- The most recent figure is from Vor Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: